News
Four out of 10 eczema patients struggle with sleep, and they may not volunteer that information unless you ask.
Parnassus Investments, an investment management firm that focuses on owning a concentrated portfolio of U.S. large-cap stocks ...
Regeneron’s second quarter was marked by robust growth in key products, which the company attributed to the strong commercial ...
In July 2025, Merck Sharp & Dohme LLC announced a substudy is to assess the efficacy and safety of ifinatamab deruxtecan ...
15h
TipRanks on MSNRegeneron’s Latest Clinical Trial: A New Hope for Advanced Cancer Treatment
Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Study Overview: Regeneron Pharmaceuticals is conducting a ...
Regeneron Pharmaceuticals (($REGN)) announced an update on their ongoing clinical study. Regeneron Pharmaceuticals is conducting a Phase 3 ...
The project aims to enhance AbbVie’s chemical synthesis capacity to support next-generation neuroscience, immunology, and ...
Over 100 students showcased 76 STEMI projects at the Eskom Expo East London regional fair, with the engineering category ...
President Donald Trump has called on 17 pharmaceutical companies to implement most-favored-nation drug pricing in the next 60 days.
Novo Nordisk faces challenges but offers growth potential through a weight loss pill and global expansion. Read more on why ...
Strong performance driven by over 200% growth in product revenues year-on-yearBest quarter in Alvotech’s history in terms of ...
CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today provided an update on the CX-2051 Phase 1 stud ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results